Stratec SE (STSEY)
| Market Cap | 281.95M -27.4% |
| Revenue (ttm) | 281.25M -8.7% |
| Net Income | -3.92M |
| EPS | -0.32 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 14.10 |
| Dividend | 0.07 (1.33%) |
| Ex-Dividend Date | Jun 25, 2026 |
| Volume | 100 |
| Open | 5.51 |
| Previous Close | 4.99 |
| Day's Range | 5.51 - 5.51 |
| 52-Week Range | 4.99 - 5.77 |
| Beta | 0.81 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 14, 2026 |
About Stratec SE
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is h... [Read more]
News
EQS-AFR: STRATEC SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQS Preliminary announcement financial reports: STRATEC SE / Preliminary announcement on the disclosure of financial statements STRATEC SE: Preliminary announcement of the publication of financial rep...
Stratec SE Slides: Corporate presentation
Stratec SE has posted slides in relation to its latest quarterly earnings report, which was published on August 1, 2026.
EQS-PVR: STRATEC SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: STRATEC SE STRATEC SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 20.07.2...
Stratec SE Slides: Investor presentation
Stratec SE has posted slides in relation to its latest quarterly earnings report, which was published on July 1, 2026.
Stratec SE Earnings Call Transcript: Q1 2026
Q1 2026 saw lower revenue and earnings due to timing shifts and product mix, but cash flow and leverage improved. Guidance for 2026 is confirmed, with growth and margin recovery expected in H2, and long-term targets remain intact.
Stratec SE Quarterly report: Q1 2026
Stratec SE has published its Q1 2026 quarterly earnings report on May 11, 2026.
Stratec SE Earnings release: Q1 2026
Stratec SE released its Q1 2026 earnings on May 11, 2026, summarizing the period's financial results.
Stratec SE Slides: Q1 2026
Stratec SE has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 11, 2026.
Stratec SE Earnings Call Transcript: Q4 2025
2025 saw stable revenue but lower margins amid geopolitical and supply chain challenges, with significant one-time charges impacting net income. Growth is expected to resume in 2026, driven by new product launches and efficiency gains, with margin recovery targeted by 2028.
Stratec SE Annual report: Q4 2025
Stratec SE has published its Q4 2025 annual report on April 28, 2026.
Stratec SE Earnings release: Q4 2025
Stratec SE released its Q4 2025 earnings on April 28, 2026, summarizing the period's financial results.
Stratec SE Slides: Q4 2025
Stratec SE has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on April 28, 2026.
Stratec SE Earnings Call Transcript: Q3 2025
Sales grew 2.5% year-over-year to EUR 175.6 million, with margin pressure from product mix and supply chain issues. Full-year guidance is for flat sales and lower margins, but Q4 is expected to improve. New partnerships, a syndicated loan, and market stabilization support a positive long-term outlook.
Stratec SE Quarterly report: Q3 2025
Stratec SE has published its Q3 2025 quarterly earnings report on November 7, 2025.
Stratec SE Slides: Q3 2025
Stratec SE has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 7, 2025.
Stratec SE Earnings Call Transcript: Q2 2025
H1 2025 saw 5.2% sales growth, stable gross margin, but lower EBIT margin due to FX and one-offs. Full-year guidance is confirmed, with H2 expected to be back-end loaded and driven by Analyzer Systems sales acceleration. M&A and refinancing activities are ongoing.
Stratec SE Quarterly report: Q2 2025
Stratec SE has published its Q2 2025 quarterly earnings report on August 19, 2025.
Stratec SE Slides: Q2 2025
Stratec SE has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 19, 2025.